- Published at
- by investing.com
positive
positive
Shield Therapeutics announces exclusive retail share offer By Investing.com
Shield Therapeutics announces exclusive retail share offer
News for Shield Therapeutics plc (SHIEF)
- Published at
- by gurufocus.com
positivepositiveHalf Year 2024 Shield Therapeutics PLC Earnings Presentation Transcript
Sep 04, 2024 / 03:30PM GMTPresentationSep 04, 2024 / 03:30PM GMT =====================Corporate Participants===================== * Anders Lundstrom Shi- Published at
- by globenewswire.com
mixedmixedC4X Discovery Holdings Limited announces progress on immuno-inflammation programmes and appointment of new Board members
C4X Discovery Holdings Limited C4XD announces progress on immuno-inflammation programmes and appointment of new Board members 22 July 2024 - C4X...- Published at
- by marketscreener.com
mixedmixedHBM Healthcare Investments : Invitation to Ordinary Shareholders' Meeting of 17.06.2024
HBM Healthcare Investments Ltd Bundesplatz 1, 6300 Zug Invitation to the 23rd Ordinary Shareholders' Meeting Monday,...- Published at
- by gurufocus.com
positivepositiveFull Year 2023 Shield Therapeutics PLC Earnings Presentation Transcript
Apr 30, 2024 / 01:30PM GMTPresentationApr 30, 2024 / 01:30PM GMT =====================Corporate Participants===================== * Gregory P. Madison S- Published at
- by marketscreener.com
mixedmixedEARNINGS AND TRADING: Software Circle & Beximco report higher revenue
The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Shield Therapeutics PLC -...- Published at
- by gurufocus.com
positivepositiveFull Year 2023 Shield Therapeutics PLC Trading Statement Presentation Transcript
Feb 22, 2024 / 02:00PM GMTPresentationFeb 22, 2024 / 02:00PM GMT =====================Corporate Participants===================== * Gregory P. Madison S- Published at
- by marketscreener.com
mixedmixedComptoir opens restaurant; Intercede wins contract
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: ---------- Comptoir Group PLC - Owner and operator of a chain of...- Published at
- by globenewswire.com
mixedmixedIron Deficiency Anemia Market Size and Share to Grow by 2032, Predicts DelveInsight | Leading Companies Developing Therapies - Pharmacosmos, AMAG, Shield, Akebia, Keros, Keryx Biopharmaceuticals, Sier
The dynamics of the iron deficiency anemia market are anticipated to change in the coming years owing to the improvement in the research and development...- Published at
- by marketscreener.com
positivepositiveShield Therapeutics completes USD20 million SWK financing
Shield Therapeutics PLC on Tuesday said it has now completed its USD20 million senior secured debt facility from SWK Funding LLC. Shield Therapeutics is a Gateshead Quays, England-based commercial...- Published at
- by prnewswire.com
mixedmixedIron Drugs Market size to grow by USD 3,552.86 million from 2022 to 2027: A growing number of CKD dialysis centers is an emerging trend - Technavio
/PRNewswire/ -- The iron drugs market size is forecast to increase by USD 3,552.86 million from 2022 to 2027, at a CAGR of 9.41%, according to the recent...- Published at
- by marketscreener.com
mixedmixedAIM WINNERS & LOSERS: Zytronic hit by electronic component shortages
The following stocks are the leading risers and fallers on AIM in London on Thursday. ---------- AIM - WINNERS ---------- Genedrive PLC, up 34% at 33.47 pence, 12-month range 8p-42p. The molecular... | February 9, 2023- Published at
- by marketscreener.com
mixedmixedTRADING UPDATES: Mobile Tornado loses CEO; DeepVerge revenue jumps
The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: ---------- DeepVerge PLC - Dublin-based environmental and life science... | January 9, 2023- Published at
- by marketscreener.com
mixedmixedTRADING UPDATES: Longboat Energy extends loan for drilling programme
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Cap-XX Ltd - Sydney-based maker of ultra-thin prismatic... | December 13, 2022- Published at
- by globenewswire.com
mixedmixedSales of Intravenous Iron Drugs Market is Estimated to hit US$ 6.3 Bn at a CAGR of 8.5% by year 2032-end | Future Market Insights, Inc.
Ferric Carboxymaltose to Generate nearly 50% of the Intravenous Iron Drugs Market throughout the Analysis Period. The US market for Intravenous Iron Drugs...- Published at
- by marketscreener.com
mixedmixedShield Therapeutics : Investor Presentation – H.C. Wainwright BIOCONNECT Virtual Conference
Shield Therapeutics plc Investor Presentation H.C. Wainwright BIOCONNECT Virtual Conference ... | January 7, 2022- Published at
- by marketscreener.com
positivepositiveShield Therapeutics : Licence agreement secured in Republic of Korea for Accrufer®
Shield Therapeutics plc Licence agreement secured in Republic of Korea for Accrufer® Exclusive licence agreement... | October 7, 2021- Published at
- by marketscreener.com
mixedmixedShield Therapeutics : US launch of Accrufer® confirmed for July 1, 2021
Shield Therapeutics plc US launch of Accrufer® confirmed for July 1, 2021 London, UK, June 24, 2021: Shield... | June 24, 2021- Published at
- by financialpost.com
positivepositiveShield Therapeutics PLC ("Shield") to Webcast Live at Life Sciences Investor Forum June 24th Shield invites individual and institutional investors, as well as advisors and analysts, to attend real-tim
LONDON, June 21, 2021 (GLOBE NEWSWIRE) — Shield Therapeutics PLC (STX.L), based in Newcastle-upon-Tyne, UK, focused on addressing iron deficiency with its…- Published at
- by marketscreener.com
mixedmixedShield Therapeutics PLC (“Shield”) to Webcast Live at Life Sciences Investor Forum June 24th
LONDON, June 21, 2021 -- Shield Therapeutics PLC , based in Newcastle-upon-Tyne, UK, focused on addressing iron deficiency with its lead product Feraccru®/Accrufer® , today...